116 pending office actions • 68 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19308852 | Untitled | Tract Pharmaceuticals, Inc. | JARRELL, NOBLE E | 1699 | Non-Final OA | |
| 19283387 | TRANSFER PRINTING STAMPS AND METHODS OF STAMP DELAMINATION | X-Celeprint Limited | FERGUSON SAMRETH, MARISSA LIANA | 2853 | Non-Final OA | Jul 29, 2025 |
| 19272607 | PROMOTER PROXIMAL SEQUENCES AND USES THEREOF FOR RNA MANUFACTURING | Helix Nanotechnologies Inc. | GONZALES, JOSEPHINE MARIA | 1631 | Non-Final OA | Jul 17, 2025 |
| 19041656 | METHODS OF USING COMPOSITIONS COMPRISING SBI DOMAINS | Helix Nanotechnologies Inc. | LEONARD, ARTHUR S | 1631 | Final Rejection | Jan 30, 2025 |
| 18865249 | METHODS AND SYSTEMS OF CONTINUOUS FORMING | University Of Maine System Board Of Trustees | FUNK, ERICA HARTSELL | 1741 | Non-Final OA | Nov 12, 2024 |
| 18935074 | METHODS AND USES OF MICROBIOME COMPOSITIONS | Marvelbiome, Inc. | OGUNBIYI, OLUWATOSIN A | 1645 | Non-Final OA | Nov 01, 2024 |
| 18770986 | NON-ORTHOGONAL ADDITIVE MANUFACTURING AND THE TREATMENT OF PARTS MANUFACTURED THEREOF | University Of Maine System Board Of Trustees | MORENO HERNANDEZ, JERZI H | 1743 | Non-Final OA | Jul 12, 2024 |
| 18728643 | WEARABLES, METHODS, AND SYSTEMS FOR ALERTING USERS TO HEALTH EMERGENCIES | Echas LLC | MINCHELLA, ADAM ZACHARY | 3794 | Non-Final OA | Jul 12, 2024 |
| 18735726 | DELIVERY SYSTEM AND METHOD FOR VASCULAR CLOSURE IMPLANT | Vivasure Medical Limited | GABR, MOHAMED GAMIL | 3771 | Non-Final OA | Jun 06, 2024 |
| 18669235 | FORMULATIONS, METHODS, KITS, AND DOSAGE FORMS FOR TREATING ATOPIC DERMATITIS AND FOR IMPROVED STABILITY OF AN ACTIVE PHARMACEUTICAL INGREDIENT | Libertas Bio, Inc. | ROSENTHAL, ANDREW S | 1613 | Non-Final OA | May 20, 2024 |
| 18659964 | SYSTEMS AND METHODS FOR GENERATIVE DESIGN OF CUSTOM BIOLOGICS | Pythia Labs, Inc. | ROSSI, VY BUI | 1685 | Final Rejection | May 09, 2024 |
| 18704643 | IMPLANT FOR VASCULAR CLOSURE | Vivasure Medical Limited | GABR, MOHAMED GAMIL | 3771 | Non-Final OA | Apr 25, 2024 |
| 18701070 | THERAPEUTIC AND PREVENTIVE COMPOSITIONS | Cellnutrition Ltd. | MI, QIUWEN | 1655 | Non-Final OA | Apr 12, 2024 |
| 18630488 | IMAGING SYSTEMS AND METHODS FOR TISSUE DIFFERENTIATION, E.G., FOR INTRAOPERATIVE VISUALIZATION | Cornell University | ROZANSKI, MICHAEL T | 3797 | Final Rejection | Apr 09, 2024 |
| 18627691 | SYSTEMS AND METHODS FOR FACILITATING LESION INSPECTION AND ANALYSIS | Exini Diagnostics AB | BEKELE, MEKONEN T | 2699 | Non-Final OA | Apr 05, 2024 |
| 18620662 | Expandable and Collapsible Lid System and Method | Expanding Ideas Inc. | CHU, KING M | 3735 | Final Rejection | Mar 28, 2024 |
| 18604196 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES | Marvelbiome, Inc. | DICKENS, AMELIA NICOLE | 1645 | Final Rejection | Mar 13, 2024 |
| 18593039 | TRANSFER-PRINTABLE MICRO-OPTICAL STRUCTURES | X-Celeprint Limited | PENG, CHARLIE YU | 2874 | Non-Final OA | Mar 01, 2024 |
| 18293884 | METHODS FOR REPAIRING CARTILAGE DEFECTS | Vericel Corporation | HU, ANN M | 3774 | Non-Final OA | Jan 31, 2024 |
| 18291432 | COMPOSITIONS AND METHODS FOR INHIBITION OF RAS | TheRas, Inc. | AULAKH, CHARANJIT | 1621 | Non-Final OA | Jan 23, 2024 |
| 18414293 | GENETICALLY MODIFIED HIGH PRODUCTIVITY INSECT CELL LINES AND METHODS FOR OBTAINING SAME | Virovek, Inc. | MOORE, JOHN DAVID | 1638 | Non-Final OA | Jan 16, 2024 |
| 18576880 | METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES | Olema Pharmaceuticals, Inc. | HIRAKIS, SOPHIA P | 1623 | Non-Final OA | Jan 05, 2024 |
| 18405572 | THREE-DIMENSIONAL MICRO-OPTICAL SYSTEMS | X-Celeprint Limited | PAK, SUNG H | 2874 | Non-Final OA | Jan 05, 2024 |
| 18537754 | SELECTION BY ESSENTIAL-GENE KNOCK-IN | Editas Medicine, Inc. | HILL, KEVIN KAI | 1638 | Non-Final OA | Dec 12, 2023 |
| 18537611 | METHODS AND COMPOSITIONS FOR TREATING AND MANAGING ALZHEIMER'S DISEASE | Pharmatrophix, Inc. | PARK, HAEJIN S | 1614 | Non-Final OA | Dec 12, 2023 |
| 18530831 | SYSTEMS AND METHODS FOR PREDICTING BIOCHEMICAL PROGRESSION FREE SURVIVAL IN PROSTATE CANCER PATIENTS | Exini Diagnostics AB | PEHLKE, CAROLYN A | 3799 | Final Rejection | Dec 06, 2023 |
| 18563101 | METHOD OF TREATING ESSENTIAL TREMOR | Cavion, Inc. | FETTEROLF, BRANDON J | 1626 | Non-Final OA | Nov 21, 2023 |
| 18562703 | COMPOSITIONS FOR TREATING AUTOIMMUNE, ALLOIMMUNE, INFLAMMATORY, AND MITOCHONDRIAL CONDITIONS, AND USES THEREOF | Trevor Klee | HELLMAN, KRISTINA M | 1654 | Non-Final OA | Nov 20, 2023 |
| 18561610 | CALIBRATING AN ELECTRONIC CHEMICAL SENSOR TO GENERATE AN EMBEDDING IN AN EMBEDDING SPACE | Osmo Labs, Pbc | COONS, LOGAN DOUGLAS | 2857 | Non-Final OA | Nov 16, 2023 |
| 18560651 | ADENOVIRAL HELPER PLASMID | Forge Biologics, Inc. | BEHARRY, ZANNA MARIA | 1632 | Non-Final OA | Nov 13, 2023 |
| 18490595 | MULTI-MODAL METHODS AND SYSTEMS OF DISEASE DIAGNOSIS | Universal Diagnostics, S.A. | BAUSCH, SARAE L | 1699 | Final Rejection | Oct 19, 2023 |
| 18381379 | SYSTEMS AND METHODS FOR IN-OPERATING-THEATRE IMAGING OF FRESH TISSUE RESECTED DURING SURGERY FOR PATHOLOGY ASSESSMENT | Samantree Medical SA | HURST, JONATHAN M | 1799 | Non-Final OA | Oct 18, 2023 |
| 18554883 | ADENOVIRAL GENE THERAPY VECTORS | Ensoma, Inc. | DHAR, MATASHA | 1632 | Non-Final OA | Oct 11, 2023 |
| 18285810 | MODIFICATION OF EPOR-ENCODING NUCLEIC ACIDS | Ensoma, Inc. | HUDSON, AMY ROSE | 1636 | Non-Final OA | Oct 05, 2023 |
| 18284959 | COMPOSITIONS AND METHODS FOR INDOOR AIR REMEDIATION | Neoplants SAS | MCWILLIAMS, KELSEY LYNN | 1663 | Non-Final OA | Sep 29, 2023 |
| 18470875 | ANTI-CD25 ANTIBODY AGENTS | Cancer Research Technology Limited | LI, RUIXIANG | 1674 | Non-Final OA | Sep 20, 2023 |
| 18468681 | NOVEL RECOMBINASES AND METHODS OF USE | Editas Medicine, Inc. | YU, DELPHINUS DOU YI | 1636 | Non-Final OA | Sep 15, 2023 |
| 18368218 | METHODS, SYSTEMS, AND APPARATUS FOR PREPARING AND/OR ADMINISTERING A GENE THERAPY PRODUCT | Unknown | AHMED, TASNIM M | 3783 | Non-Final OA | Sep 14, 2023 |
| 18368342 | ENHANCED E-BOOK PROVIDING REAL-TIME FEEDBACK AND GUIDED CONTENT FOR MUSICAL INSTRUCTION | Accelerando, LLC | CASTILHO, EDUARDO D | 3698 | Non-Final OA | Sep 14, 2023 |
| 18244685 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING EYE DISORDERS | Marvelbiome, Inc. | EDWARDS, JESSICA FAYE | 1657 | Non-Final OA | Sep 11, 2023 |
| 18452008 | PHARMACEUTICAL PROCESS AND INTERMEDIATES | AstraZeneca AB | OH, TAYLOR V | 1625 | Non-Final OA | Aug 18, 2023 |
| 18451386 | MODIFIED RIBONUCLEIC ACIDS AND USES THEREOF | Helix Nanotechnologies, Inc. | CHONG, KIMBERLY | 1636 | Non-Final OA | Aug 17, 2023 |
| 18277403 | ANTI-PATHOGENIC LIQUID COMPOSITIONS | Claw Biotech Holdings, LLC | KIM, DANIELLE A | 1613 | Non-Final OA | Aug 16, 2023 |
| 18013938 | PATHOGEN COLLECTION AND HANDLING SYSTEM | University Of Maine System Board Of Trustees | GERIDO, DWAN A | 1797 | Non-Final OA | Aug 15, 2023 |
| 18546317 | COMPOSITIONS AND METHODS FOR INHIBITING KRAS | Lawrence Livermore National Security, LLC | CHICKS, ASHLI ARIANA | 1626 | Non-Final OA | Aug 14, 2023 |
| 18366187 | HETEROCYCLIC AMIDE AND UREA COMPOUNDS AS JAK2 INHIBITORS | Ajax Therapeutics, Inc. | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Aug 07, 2023 |
| 18275258 | SELF-POLARIZING IMMUNE CELLS | Carisma Therapeutics Inc. | KIM, YUNSOO | 1641 | Non-Final OA | Aug 01, 2023 |
| 18274754 | CANCER THERAPY | Surge Therapeutics, Inc. | YANG, TIAN | 1674 | Non-Final OA | Jul 28, 2023 |
| 18263313 | HHLA2 BINDING AGENTS WITH NOVEL ACTIVITY | NextPoint Therapeutics, Inc. | BERHANE, SELAM | 1675 | Non-Final OA | Jul 27, 2023 |
| 18224842 | METHODS OF ALTERING PROTEIN DEPOSITION ON URINARY CATHETERS AND DEVICES | UNIVERSITY OF NOTRE DAME DU LAC | WIECZOREK, MICHAEL P | 1712 | Non-Final OA | Jul 21, 2023 |
| 18219325 | SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-BASED PREDICTION OF AMINO ACID SEQUENCES AT A BINDING INTERFACE | Pythia Labs, Inc. | FRUMKIN, JESSE P | 1685 | Non-Final OA | Jul 07, 2023 |
| 18260600 | TARGET DETECTION SYSTEMS AND METHODS | Dots Technology Corp. | TURK, NEIL N | 1798 | Non-Final OA | Jul 06, 2023 |
| 18345163 | HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY | Bhami'S Research Laboratory, Pvt. Ltd. | KIM, YUNSOO | 1641 | Non-Final OA | Jun 30, 2023 |
| 18269258 | CONSTITUTIVELY ACTIVE PAYLOADS | Kernal Biologics, Inc. | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Jun 22, 2023 |
| 18339808 | ORAL POLYPEPTIDE FORMULATIONS | Bhami'S Research Laboratory, Pvt. Ltd. | TIEN, LUCY MINYU | 1612 | Final Rejection | Jun 22, 2023 |
| 18268733 | PROTOPARVOVIRUS AND TETRAPARVOVIRUS COMPOSITIONS AND METHODS FOR GENE THERAPY | Synteny Therapeutics, Inc. | HILL, MYRON G | 1671 | Non-Final OA | Jun 21, 2023 |
| 18268393 | ADENOVIRAL SEROTYPE 35 HELPER VECTORS | Ensoma, Inc. | RIGA, MICHAEL ANGELO | 1634 | Non-Final OA | Jun 20, 2023 |
| 18268392 | ADENOVIRAL GENE THERAPY VECTORS | Ensoma, Inc. | JOHNSON, ALLISON MARIE | 1638 | Non-Final OA | Jun 20, 2023 |
| 18019470 | CLASSIFYING TUMORS AND PREDICTING RESPONSIVENESS | Insight Molecular Diagnostics Inc. | DAUNER, JOSEPH G | 1682 | Non-Final OA | Jun 16, 2023 |
| 18207246 | SYSTEMS AND METHODS FOR ASSESSING DISEASE BURDEN AND PROGRESSION | Progenics Pharmaceuticals, Inc. | TORRES, JOSE | 2664 | Non-Final OA | Jun 08, 2023 |
| 18036707 | MACHINE-LEARNED MODELS FOR SENSORY PROPERTY PREDICTION | Osmo Labs, Pbc | BRAHMACHARI, MANDRITA | 2144 | Non-Final OA | May 12, 2023 |
| 18136523 | CLASSIFICATION PROCESS SYSTEMS AND METHODS | Rayyan Systems Inc. | TITCOMB, WILLIAM D | 2178 | Non-Final OA | Apr 19, 2023 |
| 18031833 | AAV8 AFFINITY AGENTS | Avitide LLC | BRADLEY, CHRISTINA | 1654 | Non-Final OA | Apr 13, 2023 |
| 18023332 | DEVELOPMENT OF DRUG THERAPEUTIC AGENT CONTAINING ADAPTOR AND USE THEREOF | BEIJING TIANNUOJIANCHENG PHARMA TECH CO., LTD. | XIAO, YAN | 1642 | Non-Final OA | Feb 24, 2023 |
| 18021634 | IMMUNE MODULATION OF MYELOID DERIVED SUPPRESSIVE CELL FUNCTION FOR CANCER TREATMENT | Surge Therapeutics, Inc. | POPA, ILEANA | 1633 | Non-Final OA | Feb 16, 2023 |
| 18021231 | DEVICES | Sense Biodetection Limited | MUI, CHRISTINE T | 1797 | Final Rejection | Feb 14, 2023 |
| 18021076 | RESILIENT BIASED LATCH WITH FUSIBLE RETAINING MEMBER | Sense Biodetection Limited | CHIU, MAY LEUNG | 1758 | Non-Final OA | Feb 13, 2023 |
| 18016096 | PREPARATIONS AND COMPOSITIONS COMPRISING POLYMER COMBINATION PREPARATIONS | Surge Therapeutics, Inc. | WERTZ, ASHLEE ELIZABETH | 1612 | Final Rejection | Jan 13, 2023 |
| 18012262 | MRNA TRANSFECTION OF IMMUNE CELLS | Carisma Therapeutics Inc. | LEONARD, ARTHUR S | 1631 | Non-Final OA | Dec 22, 2022 |
| 18012469 | BINDING MODULATOR | Allymab, Inc. | JOHANSEN, PETER N. | 1644 | Non-Final OA | Dec 22, 2022 |
| 18085121 | APPLICATION OF CAS PROTEIN, METHOD FOR DETECTING TARGET NUCLEIC ACID MOLECULE AND KIT | Shanghai Tolo Biotechnology Company Limited | REGA, KYLE THOMAS | 1636 | Non-Final OA | Dec 20, 2022 |
| 18009832 | CRISPR-BASED SARS-COV-2 DETECTION | Sherlock Biosciences, Inc. | KINSEY WHITE, NICOLE ERIN | 1672 | Non-Final OA | Dec 12, 2022 |
| 18001340 | GENETIC MODIFICATION | Peter Biotherapeutics, Inc. | LEITH, NANCY J | 1636 | Non-Final OA | Dec 09, 2022 |
| 18062844 | TRANSFER-PRINTED MICRO-OPTICAL COMPONENTS | X-Celeprint Limited | SWANSON, ALAINA MARIE | 2872 | Non-Final OA | Dec 07, 2022 |
| 18073511 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | Marvelbiome, Inc. | REGLAS, GEORGIANA C | 1651 | Non-Final OA | Dec 01, 2022 |
| 17980755 | SYSTEMS AND METHODS FOR PREPARING BIOLOGICAL SAMPLES FOR GENETIC SEQUENCING | Universal Diagnostics, S.A. | PHAM, KHAI QUYNH TIEN | 1684 | Final Rejection | Nov 04, 2022 |
| 17923293 | METHODS AND DEVICES FOR TREATMENT OF NEUROPATHY | University Of Maine System Board Of Trustees | PRICE, NATHAN R | 3783 | Non-Final OA | Nov 04, 2022 |
| 17923358 | SELECTION BY ESSENTIAL-GENE KNOCK-IN | BLUEROCK THERAPEUTICS LP | HILL, KEVIN KAI | 1638 | Non-Final OA | Nov 04, 2022 |
| 17972484 | PRINTED DEVICES IN CAVITIES | X-Celeprint Limited | PRASAD, NEIL R | 2897 | Non-Final OA | Oct 24, 2022 |
| 17761594 | COMPOSITIONS AND METHODS FOR MICROBIOME MODULATION | Washington University | SINGH, SATYENDRA K | 1657 | Final Rejection | Oct 11, 2022 |
| 17955346 | HIGH-PRECISION PRINTED STRUCTURES AND METHODS OF MAKING | X-Celeprint Limited | POLLEY, CHRISTOPHER M | 1785 | Final Rejection | Sep 28, 2022 |
| 17914933 | METHODS FOR PRECISE AND BIAS-FREE QUANTIFICATION OF CELL-FREE DNA | Chronix Biomedical | WILDER, CYNTHIA B | 1681 | Non-Final OA | Sep 27, 2022 |
| 17911678 | A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE IN A MAMMAL | AvenCell Europe GmbH | LEE, YIE CHIA | 1642 | Final Rejection | Sep 15, 2022 |
| 17791785 | COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES | The Sallie Astor Burdine Breast Foundation | BENZION, GARY | 1681 | Non-Final OA | Jul 08, 2022 |
| 17850889 | BREAST CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | Chronix Biomedical | ZHANG, KAIJIANG | 1684 | Non-Final OA | Jun 27, 2022 |
| 17808868 | TEAD INHIBITORS AND USES THEREOF | Cedilla Therapeutics, Inc. | SEAMAN, D MARGARET M | 1625 | Non-Final OA | Jun 24, 2022 |
| 17845481 | DETECTION OF COLORECTAL CANCER | Universal Diagnostics, S.A. | MUMMERT, STEPHANIE KANE | 1681 | Non-Final OA | Jun 21, 2022 |
| 17786753 | ENGINEERED CELLS FOR THERAPY | Editas Medicine, Inc. | GONZALES, JOSEPHINE MARIA | 1631 | Non-Final OA | Jun 17, 2022 |
| 17842762 | FGF-18 IN GRAFT TRANSPLANTATION AND TISSUE ENGINEERING PROCEDURES | Merck Patent GmbH | MOSS, NATALIE M | 1653 | Non-Final OA | Jun 16, 2022 |
| 17782318 | IMPROVED METHODS AND DEVICES FOR MEASURING CELL NUMBERS AND/OR CELL PROPERTIES | Unknown | GZYBOWSKI, MICHAEL STANLEY | 1798 | Final Rejection | Jun 03, 2022 |
| 17744231 | METHODS FOR DISEASE DETECTION | Universal Diagnostics, S.A. | CASH, KAILEY ELIZABETH | 1683 | Non-Final OA | May 13, 2022 |
| 17772863 | LIGNOCELLULOSIC FOAM COMPOSITIONS AND METHODS OF MAKING THEREOF | University Of Maine System Board Of Trustees | DONAHUE, OLGA LUCIA | 1763 | Non-Final OA | Apr 28, 2022 |
| 17769518 | TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS | Kinesid Therapeutics, Inc. | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | Non-Final OA | Apr 15, 2022 |
| 17769509 | TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS | Kinesid Therapeutics, Inc. | VAJDA, KRISTIN ANN | 1622 | Final Rejection | Apr 15, 2022 |
| 17766113 | METHODS AND MATERIALS FOR TREATING NEUROTOXICITY | Cavion, Inc. | LEE, CHIHYI NMN | 1628 | Final Rejection | Apr 01, 2022 |
| 17696509 | TRANSDERMAL DELIVERY OF LARGE AGENTS | Eirion Therapeutics, Inc. | SHIN, MONICA A | 1616 | Final Rejection | Mar 16, 2022 |
| 17673581 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME | Marvelbiome, Inc. | LYONS, MARY M | 1645 | Non-Final OA | Feb 16, 2022 |
| 17588888 | MICRO-TRANSFER-PRINTABLE COMPONENT MODULES WITH A MODULE TETHER AND MICRO-COMPONENT ON A FLEXIBLE, POLYMER, OR ORGANIC MODULE SUBSTRATE | X-Celeprint Limited | MALSAWMA, LALRINFAMKIM HMAR | 2892 | Non-Final OA | Jan 31, 2022 |
| 17578873 | EMBEDDED TRANSISTOR DEVICES | X-Celeprint Limited | KARIMY, TIMOR | 2818 | Non-Final OA | Jan 19, 2022 |
| 17572403 | CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS | Editas Medicine, Inc. | SINGH, ANOOP KUMAR | 1632 | Final Rejection | Jan 10, 2022 |
| 17549800 | SYSTEMS AND METHODS FOR TREATING PATIENTS WITH (OR AT RISK FOR) ABNORMAL BLOOD CLOTS, PARTICULARLY COVID-19 PATIENTS | Unknown | PHAM, KATHERINE-PH MINH | 3781 | Non-Final OA | Dec 13, 2021 |
| 17611005 | ENGINEERED ORGANISMS AND USES THEREOF AS LIVING MEDICINES, RESEARCH TOOLS, FOOD PRODUCTS, OR ENVIRONMENTAL TOOLS | 64-X, Inc. | CHOWDHURY, IQBAL HOSSAIN | 1656 | Final Rejection | Nov 12, 2021 |
| 17610057 | DELAYING PEAK EFFECT AND/OR EXTENDING DURATION OF RESPONSE | Eirion Therapeutics, Inc. | SHIN, MONICA A | 1616 | Non-Final OA | Nov 09, 2021 |
| 17503056 | DETECTION AND QUANTIFICATION OF DONOR CELL-FREE DNA IN THE CIRCULATION OF ORGAN TRANSPLANT RECIPIENTS | Chronix Biomedical | KAPUSHOC, STEPHEN THOMAS | 1683 | Non-Final OA | Oct 15, 2021 |
| 17491676 | 3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | Rugen Holdings (Cayman) Limited | FERGUSON, JALISA HOLMES | 1626 | Final Rejection | Oct 01, 2021 |
| 17477069 | DATA SEARCHING SYSTEM AND METHOD | Certara, L.P. | SACKALOSKY, COREY MATTHEW | 2128 | Non-Final OA | Sep 16, 2021 |
| 17467674 | IMPLANTABLE SEALABLE MEMBER WITH MESH LAYER | Vivasure Medical Limited | ICET, DANIEL ALLEN | 3771 | Non-Final OA | Sep 07, 2021 |
| 17429192 | Systems and Methods for Predicting the Olfactory Properties of Molecules Using Machine Learning | Osmo Labs, Pbc | AUGER, NOAH ANDREW | 1687 | Final Rejection | Aug 06, 2021 |
| 17428995 | TREATMENT OF PATIENTS AT RISK OF RAPID PROGRESSION OF OSTEOARTHRITIS WITH AN FGF-18 COMPOUND | Merck Patent GmbH | SAOUD, CHRISTINE J | 1645 | Non-Final OA | Aug 06, 2021 |
| 17311089 | CELL SCANNING TECHNOLOGIES AND METHODS OF USE THEREOF | Unknown | AUGER, NOAH ANDREW | 1687 | Final Rejection | Jun 04, 2021 |
| 17274948 | PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) INHIBITORS AND USES THEREFOR | Eirion Therapeutics, Inc. | MCANANY, JOHN D | 1625 | Final Rejection | Mar 10, 2021 |
| 16979515 | DISPERSANT AND BINDER FOR LITHIUM ION BATTERIES BASED ON MODIFIED LIGNIN AND CARBOXYMETHYL CELLULOSE | Borregaard AS | MARTIN, ANGELA J | 1727 | Non-Final OA | Sep 09, 2020 |
| 16896899 | SHEATH-DILATOR SYSTEM AND USES THEREOF | Vivasure Medical Limited | ZAMORY, JUSTIN L | 3783 | Final Rejection | Jun 09, 2020 |
| 16806536 | RECEPTACLES FOR STAINING AND/OR RINSING SAMPLES AND METHODS OF THEIR USE | Samantree Medical SA | KUMAR, RAKESH | 3651 | Non-Final OA | Mar 02, 2020 |
| 16474198 | SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO | Editas Medicine, Inc. | VYAS, KEYUR ANILKUMAR | 1637 | Final Rejection | Jun 27, 2019 |
| 16284963 | PROSTATE CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | Chronix Biomedical | SITTON, JEHANNE SOUAYA | 1682 | Non-Final OA | Feb 25, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial